Senior Director, Clinical & Commercial Supply Chain
Remix Therapeutics
Summary
We are seeking an experienced, strategic, resourceful and highly motivated Senior Director, Clinical and Commercial Supply Chain to lead end-to-end supply planning; operational launch readiness for Remix's first commercial product, ensuring product availability, compliant distribution, and robust performance management. Reporting to the Vice President, Technical Operations, this role is ideal for a seasoned biotech supply chain leader with deep clinical supply expertise, commercial launch experience, and the ability to step into a highly visible leadership role with immediate impact.
Job description
Position Summary
We are seeking an experienced, strategic, resourceful and highly motivated Senior Director, Clinical and Commercial Supply Chain to lead end-to-end supply planning; operational launch readiness for Remix's first commercial product, ensuring product availability, compliant distribution, and robust performance management. Reporting to the Vice President, Technical Operations, this role is ideal for a seasoned biotech supply chain leader with deep clinical supply expertise, commercial launch experience, and the ability to step into a highly visible leadership role with immediate impact.
Key Responsibilities
- Own clinical supply strategy ensuring continuous supply for all Remix portfolio clinical programs.
- Own commercial supply strategy for Remix's first commercial product, launch readiness plans, demand planning and forecasting, and CMO management.
- Develop and maintain integrated demand/supply plans, developing CMO manufacturing schedules, capacity models, inventory strategy and management, and scenario analyses.
- Lead/drive S&OP cadence: monthly supply reviews, risk/opportunity assessments, mitigation actions, and executive-ready reporting.
- Lead end-to-end inventory management (GxP and SOX compliant) across the clinical and commercial supply chain, including inventory policy setting, reconciliation, cycle counting oversight, expiry tracking, and alignment with demand and production plans.
- Manage external network execution; align campaign plans and batch execution to forecasts and contractual commitments.
- Partner with Finance/Accounting for reconciliations, chargebacks, rebates, etc.
- Oversee commercial packaging readiness: secondary packaging/labeling, serialization strategy/execution, artwork lifecycle coordination, shipping lane validation, controlled shipping conditions, and exception management.
- Serve as the primary point of contact for commercial packaging, labeling, logistics, and storage vendors and develop a governance process for effective management of these vendors.
- Build and monitor KPIs/dashboards (service level, plan adherence, capacity utilization, inventory health) and lead continuous improvement of planning tools/processes.
- Partner with Quality/Regulatory/CMC to ensure GxP-compliant release and distribution readiness and alignment to registration timelines.
Qualifications
- BA/BS in Supply Chain, Engineering, Life Sciences (advanced degree preferred).
- 15+ years in biotech/pharma supply chain, including 10+ years commercial and/or late-stage launch readiness experience.
- Ability and willingness to be a hands-on leader and step into a visible role quickly with minimal supervision.
- Experience within a highly outsourced biotechnology operating model.
- Proven experience managing external manufacturing and supply partners.
- Strong understanding of GMP/GDP, regulatory timing impacts on supply, and global distribution logistics.
- Advanced planning/analytics skills (Excel and/or supply planning tools); strong cross-functional leadership and communication.
- Comfortable operating in ambiguity; able to build processes from the ground up.
- The successful candidate will be a team player with integrity, a commitment to quality, and the ability to think critically and creatively in a fast-paced, changing environment.
- Proficiency in Microsoft Office Suite and experience with collaborative platforms (e.g., SharePoint, Box) and NetSuite inventory systems.
- Willingness and ability to travel domestically and internationally as needed.
Requirements
- BA/BS in Supply Chain, Engineering, Life Sciences (advanced degree preferred)
- 15+ years in biotech/pharma supply chain
- 10+ years commercial and/or late-stage launch readiness experience
- Hands-on leader able to step into a visible role quickly with minimal supervision
- Experience within a highly outsourced biotechnology operating model
- Proven experience managing external manufacturing and supply partners
- Strong understanding of GMP/GDP, regulatory timing impacts on supply, and global distribution logistics
- Advanced planning/analytics skills (Excel and/or supply planning tools)
- Strong cross-functional leadership and communication
- Comfortable operating in ambiguity; able to build processes from the ground up
- Team player with integrity, commitment to quality, critical and creative thinking
- Proficiency in Microsoft Office Suite
- Experience with collaborative platforms (e.g., SharePoint, Box)
- Experience with NetSuite inventory systems
- Willingness and ability to travel domestically and internationally
Benefits
- Bonus
- Equity
- Health Insurance
Company overview
Remix Therapeutics is a clinical-stage biotechnology company pioneering novel approaches to RNA-targeted therapeutics. Founded in 2018 and headquartered in Watertown, Massachusetts, the company is developing small molecule therapies designed to reprogram RNA processing and address disease drivers at their origin. Remix's proprietary REMaster™ technology platform combines cutting-edge data science, biomolecular sciences, and chemistry to identify orally administered compounds that modulate gene expression by altering how genes are read from the genome. The company's lead candidate, REM-422, is a first-in-class RNA processing modulator currently in Phase 1 clinical studies for treating acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (HR-MDS), and adenoid cystic carcinoma (ACC). Remix focuses on addressing drug targets in diseases with high unmet medical need, with a particular emphasis on oncology research. The company has demonstrated promising clinical results, including a 43% overall response rate in adenoid cystic carcinoma patients, showcasing the potential of its innovative RNA-targeting approach to transform patient outcomes.